**Specifications Table**TableSubject areaBiologyMore specific subject areaStem cell biology, Developmental biology, Regenerative medicineTypes of dataImage, graph, schematic diagramHow data was acquiredInverted fluorescent microscope (fluorescent, bright-field) and Fluorescence-activated cell sorting (FACS) analysisData formatRaw, analyzedExperimental factorsMouse embryonic stem cells (ESCs) were differentiated into optic tissues *in vitro*Experimental featuresA chemical inhibitor, CHIR99021 (CHIR), which inhibits GSK-3ß, was applied for the generation of optic tissues in a three-dimensional manner using a chemically defined medium (CDM) and matrigel (MG).Data source locationLaboratory for *in vitro* Histogenesis, RIKEN Center for Developmental Biology. Center for Vascular and Developmental Biology, Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine.Data accessibilitySupplementary data of the article

**Value of the data**•The expression pattern of Sox2, Pax6 and Rax provides the characterization of ESC-derived tissues for regional identification of neural tissues.•The data and diagram for the timed-addition of reagents into the differentiation media may assist the readers in readily using the *in vitro* system for inducing optic tissues from ESCs.•A data of the ESC-derived Rax positive tissues from culture day 4 to day 24 may give better information of the ESC differentiation culture for researchers in the related fields.

1. Data {#s0005}
=======

This data mainly focuses on describing the regional marker expression of neural tissues and the data of eye tissue-inducing culture ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}), and refers to our recently published [@bib1]. We used mouse embryo and mouse ESC-derived tissue samples to analyze the regional marker expression via immunostaining and also showed the images of ESC-derived tissues in living condition. The data shown are microscopy images (Fluorescent and Bright-field), graphs (Population of GFP+cells) and schematic diagrams (Step-by-step processes).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Regional marker expressions of neuroepithelium *in vivo* and *in vitro* {#s0015}
----------------------------------------------------------------------------

Rax was expressed in the anterior neuroepithelium, which expressed Sox2 as well at embryonic day (E) 7.75 ([Fig. 1](#f0005){ref-type="fig"}A, A′) [@bib2], [@bib3]. The optic tissues at E9.5 co-expressed Rax and Pax6 ([Fig. 1](#f0005){ref-type="fig"}D, D′) [@bib4]. Using a Rax::GFP ESC line, Rax+ tissues were locally induced at culture day 4, at which point Sox2 was globally expressed in the neuroepithelial-like structure ([Fig. 1](#f0005){ref-type="fig"}B, C). Subsequently, by adding CHIR99021, Rax+/Pax6+ optic vesicle-like structures were formed at culture day 7, reminiscent of *in vivo* optic tissues ([Fig. 1](#f0005){ref-type="fig"}E, F).

2.2. Step-by-step data during generating Rax+ optic vesicle-like tissues in the CDM/MG/CHIR condition {#s0020}
-----------------------------------------------------------------------------------------------------

From here we describe data for generating Rax+ optic vesicle-like tissues using mouse ESCs ([Fig. 2](#f0010){ref-type="fig"}A). ESCs were maintained in maintenance medium before differentiation [@bib5]([Fig. 2](#f0010){ref-type="fig"}A, B). At day 0, we performed SFEBq (Serum-free Floating culture of Embryoid Body-like aggregates with quick reaggregation) [@bib6]. ESCs were dissociated and quickly aggregated in the non-adhesion coated 96 wells ([Fig. 2](#f0010){ref-type="fig"}D). 30 min later, we could observe the beginning of aggregation and, 6 h later, cells had mostly aggregated ([Fig. 2](#f0010){ref-type="fig"}C, E). At day 1, 2% matrigel was directly added into the medium ([Fig. 2](#f0010){ref-type="fig"}F). At day 2, the surface portion of the day-2 aggregate was changed morphologically ([Fig. 2](#f0010){ref-type="fig"}G). By day 4, neurorpithelial-like structures expressing apico-basal polarity marker, N-cadherin (inside), and Laminin (outside) were observed ([Fig. 2](#f0010){ref-type="fig"}H, J). Simultaneously, Rax::GFP cells started to faintly appear in the epithelial-like structure ([Fig. 2](#f0010){ref-type="fig"}I, K). This time (day 4), 2 µM CHIIR99021 was added, which inhibited GSK-3ß. At day 7, Rax+ optic vesicle-like structures were generated ([Fig. 2](#f0010){ref-type="fig"}L, M). Subsequently, at day 7, we replaced CDM with DMEM/F12/N2/10% FBS (fetal bovine serum) medium to grow tissues for long-term culture ([Fig. 2](#f0010){ref-type="fig"}A). At day 10, we chopped Rax+ tissue portions which also expressed Pax6 in order to separate them from other tissues ([Fig. 2](#f0010){ref-type="fig"}N). From day 10, we precisely followed the method reported previously [@bib5]. We confirmed that day-18 tissues mostly expressed Rax::GFP ([Fig. 2](#f0010){ref-type="fig"}O, O′) and day-24 tissues expressed Rax::GFP and Recoverin, which is expressed in the photoreceptor cells of the eyes *in vivo* [@bib7], [@bib8] ([Fig. 2](#f0010){ref-type="fig"}P). The addition of 0.5 or 3 µM CHIR99021 from day 4 to day 7 did not efficiently: induce the formation of Rax+ vesicle-like structure ([Fig. 2](#f0010){ref-type="fig"}Q).

2.3. ESC culture and reagents {#s0025}
-----------------------------

ES cell maintenance; Using ESC-qualified Fetal calf serum (FCS) and KnockOut Serum Replacement, a Rax::GFP knock-in ESC line was maintained as described previously [@bib5]. ES cell differentiation; Based on SFEBq using Nunclon Sphera 96U Bottom Plate (Thermo Scientific, 174925) [@bib6], the differentiation method was performed in the CDM/MG/CHIR condition for inducing Rax+ optic vesicle-like tissues. CDM was prepared as follows: IMDM, GlutaMAX™ Supplement (Thermo Fisher Scientific, 31980030)/ Ham׳s F-12 Nutrient Mix, GlutaMAX™ Supplement (Thermo Fisher Scientific, 31765035) 1:1, 1x Chemically Defined Lipid Concentrate (Thermo Fisher Scientific, 11905031), 450 µM 1-Thioglycerol (SIGMA-ALDRICH, M6145), 5 mg/ml Bovine Serum Albumin (SIGMA-ALDRICH, A3156) and 15 µg/ml apo-Transferrin bovine (SIGMA-ALDRICH, T1428). At day 0, ESC were dissociated into single cells and the number of cells was counted via trypan-blue staining (SIGMA-ALDRICH, T8154 for excluding dead cells) to seed 3000 cells per well in CDM. At day 1, 2% (vol/vol) of matrigel, growth factor reduced (BD, 354230) were added. The final protein concentration of matrigel is typically 200 µg/ml (from around 10 mg/ml protein concentration) and several matrigel lots are routinely tested using a previous eye inducing protocol [@bib5]. At day 4, 2 µM CHIR99021 (STEMGENT, 04-0004) was added. Infrequently, ESC-derived tissue at day 4 does not expressed Rax::GFP (typically due to ESC-passage number or incorrect ESC maintenance state). In this case, the addition of CHIR99021 led to the formation of Rax negative tissues at day 7 (data not shown). At day 7, ESC-derived tissues were transferred into DMEM/F12/N2/Penicillin-Streptomycin (PS), containing 10% FBS (vol/vol). At day 10, from here, ESC-derived tissue were grown exactly the same as previously published [@bib5], and its process is also briefly shown in [Fig. 2](#f0010){ref-type="fig"}A.

2.4. Immunostaining and acquiring images {#s0030}
----------------------------------------

Slc:ICR mouse embryos were purchased from Japan SLC, Inc. to serve as a positive control. Immunostaining of cryosectioned samples was performed as previously described [@bib9]. Primary antibodies were used as follows: GFP (rat, 1/500, NACALAI, 04404-84), Sox2 (goat, 1/250, santa cruz, sc-17320), Rax (guinea pig, 1/1000, TaKaRa custum, MS8407-3), Pax6 (mouse, 1/500, R&D, MAB1260), N-cadherin (mouse, 1/1000, BD, 610920), Laminin (rat, 1/1000, CHEMICON, MAB1905) and Recoverin (rabbit, 1/1000, chemicon, AB5585). DAPI was used for counter staining. Immunofluorescent images were taken by LSM710 or 780 (Zeiss). For the visualization of living ESCs and ESC-derived tissues, KEYENCE (KEYENCE) and EVOS (Thermo Fisher) microscopes were used. Acquired images were merged using Photoshop and ImageJ softwares.

2.5. Fluorescence-activated cell sorting (FACS) analysis {#s0035}
--------------------------------------------------------

FACS analysis was performed as previously described [@bib9].

Transparency document. Supplementary material {#s0045}
=============================================
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![Comparison between *in vivo* and *in vitro* marker gene expression in the neuroepithelium and optic tissues. (A, B, C) E7.75 embryo and day-4 ESC-derived tissues show Sox2, Rax and Rax::GFP signals via immunostaining. Image B and C are prior to CHIR addition. Image A′ is a high magnification of the forebrain region in Image A. Dotted lines in image C indicate epithelial-like structures. (D, E, F) E9.5 embryo and day-7 ESC-derived tissues in CDM/MG/CHIR condition show Pax6, Rax and Rax::GFP signals via immunostaining. Image D' is a high magnification of the eye region in image D. Scale bars; 100 µm.](gr1){#f0005}

![Schematic diagrams and data for the generation of optic tissues from mouse ESCs *in vitro*. (A) A brief step by step instruction in the CDM/MG/CHIR condition. (B, C, E--H, K--M, O, O′, Q) Transillumination and fluorescent images of living cells and tissues. Trans, transillumination. Images B, C, E-G were acquired via EVOS microscope. (D) Schematic of the quick reaggregation of ESCs. (I) FACS analysis of ESC-derived day-4 cell. ESC serves as a negative control. (J, N, P). Immunostaining of ESC-derived tissues showing N-cadherin (Ncad), Laminin, Pax6, Rax::GFP and Recoverin. Day-4 data are prior to CHIR addition. CDM, chemically defined medium. MG, matrigel. CHIR, CHIR99021. PS, Penicillin-Streptomycin. RA, Retinoic acid. Scale bars; 100 µm.](gr2){#f0010}
